R&G PharmaStudies Co

R&G PharmaStudies Co P/B

The P/B (Price-to-Book Ratio) of R&G PharmaStudies Co (301333.SZ) as of Nov 17, 2026 is 3.68. In the previous year, P/B (Price-to-Book Ratio) was 3.95 — a change of -6.89% (lower).

P/B

3.68

YoY

-6.89%

Last updated:

P/B (Price-to-Book Ratio) of R&G PharmaStudies Co is 2025 3.68 . P/B (Price-to-Book Ratio) of R&G PharmaStudies Co was 2024 3.95 . It decreases by -6.89% lower compared to the previous year.

The R&G PharmaStudies Co P/B history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/B
Date
P/B
Jan 1, 2019
30.48 CNY
Jan 1, 2020
22.45 CNY
Jan 1, 2021
17.15 CNY
Jan 1, 2022
4.56 CNY
Jan 1, 2023
4.14 CNY
Jan 1, 2024
3.95 CNY
Jan 1, 2025
3.68 CNY
The R&G PharmaStudies Co P/B history
YEARP/BYoY
3.68-6.89%
3.95-4.59%
4.14-9.19%
4.56-73.39%
17.15-23.60%
22.45-26.36%
30.48—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

R&G PharmaStudies Co Stock analysis

What does R&G PharmaStudies Co do? R&G PharmaStudies Co Ltd, based in Beijing, China, provides clinical trial outsourcing services within the Health Care sector. The company offers a range of services including clinical trial operations, site management, biological sample testing, data management, statistical analysis, consulting, and clinical pharmacology. With 1,926 employees, it operates primarily in the domestic Chinese market and was listed on the stock market on 2 August 2022. R&G PharmaStudies Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about R&G PharmaStudies Co stock

P/B (Price-to-Book Ratio) of R&G PharmaStudies Co is 3.68 in 2025.

P/B (Price-to-Book Ratio) of R&G PharmaStudies Co changed from 3.95 to 3.68, representing a -6.89% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) R&G PharmaStudies Co since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s R&G PharmaStudies Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — R&G PharmaStudies Co

All Key Metrics — R&G PharmaStudies Co